Male | 1 | - | - |
Female | 1.03 | 0.99–1.07 | 0.116 |
<40 | 1.85 | 1.41–2.41 | <0.001 |
40–49 | 1.63 | 1.44–1.83 | <0.001 |
50–59 | 1.16 | 1.08–1.25 | <0.001 |
60–69 | 1.01 | 0.96–1.06 | 0.736 |
70–79 | 1 | - | - |
80–89 | 1.09 | 1.02–1.14 | 0.008 |
>90 | 1.68 | 1.50–1.89 | <0.001 |
Stage IA | 1 | - | - |
Stage IB | 1.03 | 0.89–1.19 | 0.693 |
Stage IIA | 1.32 | 1.03–1.68 | 0.025 |
Stage IIB | 1.25 | 1.07–1.46 | 0.006 |
Stage IIIA | 1.27 | 1.11–1.46 | <0.001 |
Stage IIIB | 1.77 | 1.57–2.01 | <0.001 |
Stage IV | 2.28 | 2.03–2.56 | <0.001 |
Stage Unknown | 1.78 | 1.58–2.01 | <0.001 |
PS 0 | 1 | - | - |
PS 1 | 1.58 | 1.46–1.70 | <0.001 |
PS 2 | 2.86 | 2.64–3.09 | <0.001 |
PS 3 | 4.93 | 4.55–5.33 | <0.001 |
PS 4 | 7.19 | 6.54–7.91 | <0.001 |
PS Unknown | 2.63 | 2.42–2.85 | <0.001 |
| | | |
Co-morbidity absent | 1 | - | - |
Co-morbidity present | 0.93 | 0.89–0.98 | 0.008 |
| | | |
IMD Quintile 1 (least deprived) | 1 | - | - |
IMD Quintile 2 | 1.02 | 0.96–1.08 | 0.601 |
IMD Quintile 3 | 0.99 | 0.93–1.06 | 0.833 |
IMD Quintile 4 | 1.09 | 1.02–1.16 | 0.007 |
IMD Quintile 5 (most deprived) | 1.06 | 1.00–1.13 | 0.059 |